Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Instant draw volume results Enter vial size and target research quantity get the exact draw volume in seconds
Human research has also measured na
RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
If youve experienced any decline in performance as youve gotten older please try BPC-157/TB-500
US$ 25.34
US$ 24.38
US$ 29.46
US$ 20.63
US$ 21.38
US$ 25.54
US$ 25.79
US$ 22.24
US$ 29.65
US$ 25.73
US$ 26.42
